Market revenue in 2023 | USD 41.0 million |
Market revenue in 2030 | USD 65.6 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Echocardiography |
Fastest growing segment | Radionuclide cardiac imaging |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radionuclide cardiac imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging |
Key market players worldwide | Toshiba Corporation, Hologic Inc, Carestream Health - HCIS business, GE HealthCare Technologies Inc Common Stock, Siemens Healthineers AG ADR, Koninklijke Philips NV, Hitachi Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive coronary imaging market will help companies and investors design strategic landscapes.
Echocardiography was the largest segment with a revenue share of 30.24% in 2023. Horizon Databook has segmented the Europe non-invasive coronary imaging market based on radionuclide cardiac imaging, echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held a significant market share owing to the presence of various key players in the region, increasing prevalence of cancer, and supportive government initiatives. For instance, as per WHO, more than 3.7 million new cancer cases are diagnosed, and 1.9 million deaths occur due to cancer every year.
Moreover, it reported that cancer is the second major cause of morbidity and death in the region. Extensive efforts being undertaken by the European Commission to control hazards caused by the usage of phthalates and PVC as raw materials in the production of medical devices are boosting the market.
For instance, in 2012, a ban was announced on the use of phthalates in the manufacturing of medical devices by the French government, which was imposed in 2015. This ban is expected to boost the adoption of non-PVC alternatives such as non-PVC IV bags. As a result of the widespread movement across Europe, which aimed at eliminating PVC, 62 Spanish cities have been declared PVC-free.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe non-invasive coronary imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Europe non-invasive coronary imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account